[ACCESS RESTRICTED TO THE UNIVERSITY OF MISSOURI AT REQUEST OF AUTHOR.] Estradiol protects women from various cardiovascular and metabolic diseases, a protection which is lost with menopause when estradiol levels drop. Estrogen receptor beta (ERb), one of the two major estrogen receptors in the body, acts via genomic and non-genomic signaling pathways to affect many metabolic functions, including mitochondrial biogenesis and respiration. This study explores the effect of the non-genomic pathway of ERb on adipocyte mitochondria and insulin resistance by assessing the influence of ovariectomy, a model of menopause, and exercise in mice lacking the ERb DNA-binding domain (DBD). Specifically, 21 wild-type (WT) mice and 20 ERb DBD-knockout (KO) ...
Loss of ovarian hormones (ie. menopause) results in a significant increase in risk for developing th...
Background: The incidence of chronic disease is elevated in women after menopause. Natural variation...
International audienceThe beneficial metabolic actions of estrogen-based therapies are mainly mediat...
Menopause puts a female at risk for several chronic diseases, including an increased risk of obesity...
Menopause puts a female at risk for several chronic diseases, including an increased risk of obesity...
Skeletal muscle is an important tissue responsible for locomotion, oxidative metabolism, and insulin...
The maintenance of glucose homeostasis within the body is crucial for constant and precise performan...
Metabolic disease risk escalates following menopause. The mechanism is not fully known, but likely i...
Objective: Studies using the estrogen receptor alpha (ERα) knock-out (αERKO) mice have demonstrated ...
White adipose tissue (WAT) dysfunction independently predicts cardiometabolic disease, yet there is ...
International audienceThe beneficial metabolic actions of estrogen-based therapies are mainly mediat...
White adipose tissue (WAT) dysfunction independently predicts cardiometabolic disease, yet there is ...
White adipose tissue (WAT) dysfunction independently predicts cardiometabolic disease, yet there is ...
White adipose tissue (WAT) dysfunction independently predicts cardiometabolic disease, yet there is ...
White adipose tissue (WAT) dysfunction independently predicts cardiometabolic disease, yet there is ...
Loss of ovarian hormones (ie. menopause) results in a significant increase in risk for developing th...
Background: The incidence of chronic disease is elevated in women after menopause. Natural variation...
International audienceThe beneficial metabolic actions of estrogen-based therapies are mainly mediat...
Menopause puts a female at risk for several chronic diseases, including an increased risk of obesity...
Menopause puts a female at risk for several chronic diseases, including an increased risk of obesity...
Skeletal muscle is an important tissue responsible for locomotion, oxidative metabolism, and insulin...
The maintenance of glucose homeostasis within the body is crucial for constant and precise performan...
Metabolic disease risk escalates following menopause. The mechanism is not fully known, but likely i...
Objective: Studies using the estrogen receptor alpha (ERα) knock-out (αERKO) mice have demonstrated ...
White adipose tissue (WAT) dysfunction independently predicts cardiometabolic disease, yet there is ...
International audienceThe beneficial metabolic actions of estrogen-based therapies are mainly mediat...
White adipose tissue (WAT) dysfunction independently predicts cardiometabolic disease, yet there is ...
White adipose tissue (WAT) dysfunction independently predicts cardiometabolic disease, yet there is ...
White adipose tissue (WAT) dysfunction independently predicts cardiometabolic disease, yet there is ...
White adipose tissue (WAT) dysfunction independently predicts cardiometabolic disease, yet there is ...
Loss of ovarian hormones (ie. menopause) results in a significant increase in risk for developing th...
Background: The incidence of chronic disease is elevated in women after menopause. Natural variation...
International audienceThe beneficial metabolic actions of estrogen-based therapies are mainly mediat...